Thyroid eye disease is a chronic autoimmune disorder causing inflammation in the muscles and other tissues behind the eye. It can lead to other eye complications, including glaucoma. Thyroid eye ...
Thyroid eye disease (TED) therapy Tepezza – the top asset in Amgen's $26 billion takeover of Horizon in 2023 – could be facing competition from an easier-to-dose alternative from Sling ...
A new translational study from Italy suggests that use of proton-pump inhibitors (PPIs) may reduce the risk of scar formation in patients with thyroid eye disease by interrupting proliferation and ...
Illustrating the Progression of Thyroid Eye Disease Thyroid Eye Disease often causes quality-of-life changes for patients. Endocrinologist Malini Gupta, MD, demonstrates the structural changes of ...
Modifiable risk factors for thyroid eye disease include smoking habits and patient endocrine status. Avoid treating patients with active TED with radioactive iodine ablation. KOLOA, Hawaii ...
Background The purpose of this retrospective follow-up study is to evaluate the prevalence of patients with thyroid eye disease presenting with apparent unilateral proptosis and determine the ...
The FDA has granted a fast review for Horizon Therapeutics’ teprotumumab for active thyroid eye disease (TED), a rare vision-threatening autoimmune condition. After accepting Horizon’s filing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback